Follow the people · Insider
Holly B. Kordasiewicz
Holly B. Kordasiewicz files insider transactions with the SEC as an evp, chief development officer of Ionis Pharmaceuticals (IONS). We hold 3 disclosed purchases and sales filed since 6 January 2026, 2 of them in the last 90 days.
- Files forIONS
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure9 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 2 January 2026 — 7 July 2026EVP, Chief Development Officer · Ionis Pharmaceuticals (IONS)25 Form 4 lines · source: SEC Form 4
Everything they disclosed
25 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 362 shares of Ionis PharmaceuticalsSEC Form 49 July 2026Common Stock · traded 7 July 2026 · filed 9 July 2026
- exercised options over 7,951 shares of Ionis PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- exercised options over 21,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 416 June 2026Non-Qualified Stock Option (right to buy) · traded 12 June 2026 · filed 16 June 2026
- exercised options over 21,000 shares of Ionis PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- exercised options over 12,000 shares of Ionis PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- exercised options over 19,895 shares of Ionis PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- ▼ sold on the open market 41,004 shares of Ionis PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- ▼ sold on the open market 19,842 shares of Ionis PharmaceuticalsSEC Form 416 June 2026Common Stock · traded 12 June 2026 · filed 16 June 2026
- exercised options over 12,000 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 416 June 2026Non-Qualified Stock Option (right to buy) · traded 12 June 2026 · filed 16 June 2026
- exercised options over 19,895 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 416 June 2026Non-Qualified Stock Option (right to buy) · traded 12 June 2026 · filed 16 June 2026
- exercised options over 7,951 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 416 June 2026Non-Qualified Stock Option (right to buy) · traded 12 June 2026 · filed 16 June 2026
- exercised options over 11,119 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- ▼ sold on the open market 4,141 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 16 January 2026 · filed 20 January 2026
- exercised options over 11,119 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- exercised options over 11,119 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 13,650 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 11,250 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 13,650 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- was granted 11,250 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Restricted Stock Unit · traded 15 January 2026 · filed 20 January 2026
- exercised options over 11,119 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- ▼ sold on the open market 4,141 shares of Ionis PharmaceuticalsSEC Form 420 January 2026Common Stock · traded 16 January 2026 · filed 20 January 2026
- was granted 7,500 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 20 January 2026
- was granted 7,500 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 420 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 20 January 2026
- was granted 9,100 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 9,100 shares of Ionis Pharmaceuticals (a derivative holding)SEC Form 46 January 2026Non-Qualified Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.